| pubmed-article:16284747 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:16284747 | lifeskim:mentions | umls-concept:C0007226 | lld:lifeskim |
| pubmed-article:16284747 | lifeskim:mentions | umls-concept:C0286651 | lld:lifeskim |
| pubmed-article:16284747 | lifeskim:mentions | umls-concept:C0011847 | lld:lifeskim |
| pubmed-article:16284747 | lifeskim:mentions | umls-concept:C1274040 | lld:lifeskim |
| pubmed-article:16284747 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
| pubmed-article:16284747 | lifeskim:mentions | umls-concept:C0947504 | lld:lifeskim |
| pubmed-article:16284747 | lifeskim:mentions | umls-concept:C0282116 | lld:lifeskim |
| pubmed-article:16284747 | lifeskim:mentions | umls-concept:C2603343 | lld:lifeskim |
| pubmed-article:16284747 | lifeskim:mentions | umls-concept:C1553467 | lld:lifeskim |
| pubmed-article:16284747 | lifeskim:mentions | umls-concept:C0439831 | lld:lifeskim |
| pubmed-article:16284747 | pubmed:issue | 12 | lld:pubmed |
| pubmed-article:16284747 | pubmed:dateCreated | 2005-12-1 | lld:pubmed |
| pubmed-article:16284747 | pubmed:abstractText | The aim of this study was to determine the pattern of the effect of the 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor atorvastatin on cardiovascular events in patients with type 2 diabetes and no prior history of cardiovascular disease (CVD). | lld:pubmed |
| pubmed-article:16284747 | pubmed:language | eng | lld:pubmed |
| pubmed-article:16284747 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16284747 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:16284747 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16284747 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16284747 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16284747 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16284747 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16284747 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:16284747 | pubmed:month | Dec | lld:pubmed |
| pubmed-article:16284747 | pubmed:issn | 0012-186X | lld:pubmed |
| pubmed-article:16284747 | pubmed:author | pubmed-author:DurringtonP... | lld:pubmed |
| pubmed-article:16284747 | pubmed:author | pubmed-author:FullerJ HJH | lld:pubmed |
| pubmed-article:16284747 | pubmed:author | pubmed-author:BetteridgeD... | lld:pubmed |
| pubmed-article:16284747 | pubmed:author | pubmed-author:HitmanG AGA | lld:pubmed |
| pubmed-article:16284747 | pubmed:author | pubmed-author:ColhounH MHM | lld:pubmed |
| pubmed-article:16284747 | pubmed:author | pubmed-author:ThomasonM JMJ | lld:pubmed |
| pubmed-article:16284747 | pubmed:author | pubmed-author:LivingstoneS... | lld:pubmed |
| pubmed-article:16284747 | pubmed:author | pubmed-author:NeilH A WHA | lld:pubmed |
| pubmed-article:16284747 | pubmed:author | pubmed-author:CARDS... | lld:pubmed |
| pubmed-article:16284747 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:16284747 | pubmed:volume | 48 | lld:pubmed |
| pubmed-article:16284747 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:16284747 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:16284747 | pubmed:pagination | 2482-5 | lld:pubmed |
| pubmed-article:16284747 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:16284747 | pubmed:meshHeading | pubmed-meshheading:16284747... | lld:pubmed |
| pubmed-article:16284747 | pubmed:meshHeading | pubmed-meshheading:16284747... | lld:pubmed |
| pubmed-article:16284747 | pubmed:meshHeading | pubmed-meshheading:16284747... | lld:pubmed |
| pubmed-article:16284747 | pubmed:meshHeading | pubmed-meshheading:16284747... | lld:pubmed |
| pubmed-article:16284747 | pubmed:meshHeading | pubmed-meshheading:16284747... | lld:pubmed |
| pubmed-article:16284747 | pubmed:meshHeading | pubmed-meshheading:16284747... | lld:pubmed |
| pubmed-article:16284747 | pubmed:meshHeading | pubmed-meshheading:16284747... | lld:pubmed |
| pubmed-article:16284747 | pubmed:meshHeading | pubmed-meshheading:16284747... | lld:pubmed |
| pubmed-article:16284747 | pubmed:meshHeading | pubmed-meshheading:16284747... | lld:pubmed |
| pubmed-article:16284747 | pubmed:meshHeading | pubmed-meshheading:16284747... | lld:pubmed |
| pubmed-article:16284747 | pubmed:meshHeading | pubmed-meshheading:16284747... | lld:pubmed |
| pubmed-article:16284747 | pubmed:meshHeading | pubmed-meshheading:16284747... | lld:pubmed |
| pubmed-article:16284747 | pubmed:year | 2005 | lld:pubmed |
| pubmed-article:16284747 | pubmed:articleTitle | Rapid emergence of effect of atorvastatin on cardiovascular outcomes in the Collaborative Atorvastatin Diabetes Study (CARDS). | lld:pubmed |
| pubmed-article:16284747 | pubmed:affiliation | The Conway Institute, University College Dublin, Belfield, Dublin 4, Ireland. helen.colhoun@ucd.ie | lld:pubmed |
| pubmed-article:16284747 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:16284747 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:16284747 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16284747 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16284747 | lld:pubmed |
